Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why 2015 is the year of the biopharma blockbuster—with charts
Why 2015 is the year of the biopharma blockbuster—with charts
Why 2015 is the year of the biopharma blockbuster—with charts
Submitted by
admin
on March 24, 2015 - 10:29am
Source:
BioPharma Dive
News Tags:
biotech
Opdivo
Praluent
LCZ696
Ibrance
Viekira Pak
evolocumab
Gardasil 9
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
Vertex Pharmaceuticals
Merck
Amgen
AbbVie
Astellas
Headline:
Why 2015 is the year of the biopharma blockbuster—with charts
Do Not Allow Advertisers to Use My Personal information
